Health Catalyst, Inc.
NASDAQ:HCAT · NASDAQ Global Select
-$0.04 today
Vol 1.96M · Avg 1.24M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $59.9M |
| Short-term Investments | $49.0M |
| Receivables | $59.1M |
| Other Current | $14.3M |
| Total Current Assets | $182.3M |
| PP&E (Net) | $41.2M |
| Goodwill | $113.3M |
| Intangible Assets | $69.3M |
| Other Non-current | $6.1M |
| Total Non-current Assets | $229.9M |
| Total Assets | $412.2M |
Analysis
Selected assets total $412.2M for Latest. The largest visible component is Goodwill at $113.3M, about 27.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50.8M -79.6% | $249.6M +134.9% | $106.3M -8.6% | $116.3M -39.8% | $193.2M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $44.9M -68.4% | $142.4M -32.7% | $211.5M -14.5% | $247.2M -1.8% | $251.8M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $59.1M +3.4% | $57.2M -5.2% | $60.3M +25.7% | $48.0M -1.7% | $48.8M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $14.4M -12.3% | $16.5M +7.1% | $15.4M -5.9% | $16.3M +11.8% | $14.6M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $169.3M -63.6% | $465.6M +18.4% | $393.4M -8.0% | $427.8M -15.9% | $508.4M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $40.5M -2.3% | $41.5M +4.6% | $39.6M -6.9% | $42.6M -4.2% | $44.4M | $1.2B | $1.5B | $687.8M |
| Goodwill | $209.1M -19.5% | $259.8M +36.2% | $190.7M +2.5% | $186.0M +9.4% | $170.0M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $77.7M -9.7% | $86.1M +17.3% | $73.4M -20.4% | $92.2M -12.0% | $104.8M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $6.1M +1.5% | $6.0M +26.9% | $4.7M +27.0% | $3.7M -16.9% | $4.5M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $333.3M -15.2% | $393.3M +27.5% | $308.4M -5.0% | $324.5M +0.2% | $323.7M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $502.6M -41.5% | $858.9M +22.4% | $701.8M -6.7% | $752.3M -9.6% | $832.1M | $13.3B | $11.9B | $10.6B |
| Account Payables | $9.4M -18.1% | $11.4M +72.2% | $6.6M +50.1% | $4.4M -5.7% | $4.7M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $1.6M -99.3% | $231.2M | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $56.1M +5.3% | $53.3M -4.4% | $55.8M +1.4% | $55.0M -3.0% | $56.6M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $5.2M -55.4% | $11.7M -0.2% | $11.7M +55.5% | $7.5M -30.9% | $10.9M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $89.6M -72.5% | $325.9M +266.0% | $89.0M +7.9% | $82.5M -11.3% | $93.1M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $151.6M +0.3% | $151.2M -33.7% | $228.0M +0.7% | $226.5M +25.2% | $180.9M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $410.0K +64.7% | $249.0K +223.4% | $77.0K -26.7% | $105.0K -88.7% | $929.0K | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $798.0K +418.2% | $154.0K +108.1% | $74.0K -38.8% | $121.0K -99.2% | $14.8M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $167.3M -0.3% | $167.9M -31.7% | $245.9M +0.4% | $244.8M +12.8% | $216.9M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $256.9M -48.0% | $493.7M +47.4% | $334.9M +2.3% | $327.3M +5.6% | $310.0M | $14.7B | $3.7B | $9.6B |
| Common Stock | $1.6B +3.6% | $1.6B +4.6% | $1.5B +4.2% | $1.4B +2687977.4% | $53.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$1.4B -15.0% | -$1.2B -6.2% | -$1.1B -11.8% | -$999.0M -13.7% | -$878.9M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $1.6M +289.9% | -$835.0K -2630.3% | $33.0K +105.1% | -$648.0K -867.2% | -$67.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $245.8M -32.7% | $365.2M -0.5% | $366.9M -13.7% | $425.0M -18.6% | $522.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $171.2M -57.4% | $402.3M +61.5% | $249.1M +0.4% | $248.0M +21.2% | $204.6M | $724.2M | $410.6M | $399.4M |
| Net Debt | $120.4M -21.1% | $152.6M +6.9% | $142.8M +8.5% | $131.7M +1056.6% | $11.4M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$329.69M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$293.93M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$233.55M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.69M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$118.77M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$118.47M
Solana Company
NASDAQ:HSDT
$94.00M
Outset Medical, Inc.
NASDAQ:OM
$87.68M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$78.81M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does HCAT have?
Health Catalyst, Inc. (HCAT) reported $50.81M in cash and equivalents in fiscal 2025.
How much debt does HCAT carry?
Health Catalyst, Inc. (HCAT) reported $171.24M of total debt, with net debt of $120.42M.
Explore More
Continue the stock analysis
Jump to another research area for this company.